Andrew Jallouk, MD, PhD is an Assistant Professor of Medicine at Vanderbilt University Medical Center. He is a physician-scientist with a particular interest in translational research involving engineered cell therapies. His laboratory focuses on developing strategies to improve efficacy and minimize toxicity of both autologous and allogeneic cell therapies. He is also the site PI on several clinical trials pertaining to CAR T cell therapy and maintains an active clinic with a focus on lymphoid malignancies.